Solve Therapeutics, a biopharmaceutical company developing novel antibody-based therapeutics, acquired Cereius Inc., a private company developing next-generation targeted radio diagnostics and radiotherapeutics for cancer patients. In a statement, SolveTx said that it will continue to refine the chemistry platform while developing targeted radionuclide therapeutics and evaluating companion radio diagnostics for use together with other types of targeted cancer therapeutics. The company is buil...